Thursday, May 21, 2026
Today's Print

Tag: 90 percent effective

Pfizer says COVID-19 vaccine 90% effective in Phase 3 trial

A vaccine jointly developed by Pfizer and BioNTech was 90 percent effective in preventing COVID-19 infections in ongoing Phase 3 trials, the companies announced...
- Advertisement -spot_img
- Advertisement -spot_img